ArticleEuropean journal of medical research2023

Triple-tyrosine kinase inhibition by BIBF1000 attenuates airway and pulmonary arterial remodeling following chronic allergen challenges in mice.

Malarvizhi Gurusamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.